Skip to main content

Animations

MJFF Publications

4981 - 4990 of 8606 Results
Title
Year
  • Year
  • 2023
  • 2024
  • 2015
  • 2020
  • 2021
  • 2020
  • 2022
  • 2020
  • 2024
  • 2015
  • Summary Details
    OPEN
    Title: Association of sulfonylureas with the risk of dementia: A population‐based cohort study
    Journal Name: Journal of the American Geriatrics Society
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1111/jgs.18397
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Identification and structural characterization of small molecule inhibitors of PINK1
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-024-58285-3
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Quantitative comparison of 21 protocols for labeling hippocampal subfields and parahippocampal subregions in in vivo MRI: Towards a harmonized segmentation protocol
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2015.01.004
    Best OA location URL:
    Citation Count: 332
  • Summary Details
    OPEN
    Title: From iPS Cells to Rodents and Nonhuman Primates: Filling Gaps in Modeling Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/mds.28387
    Best OA location URL:
    Citation Count: 16
  • Summary Details
    RESTRICTED
    Title: Evaluation of a Low-Toxicity PARP Inhibitor as a Neuroprotective Agent for Parkinson’s Disease
    Journal Name: Molecular Neurobiology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s12035-021-02371-4
    Best OA location URL:
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Fluctuation Imaging of LRRK2 Reveals that the G2019S Mutation Alters Spatial and Membrane Dynamics
    Journal Name: Molecules
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/molecules25112561
    Citation Count: 4
  • Summary Details
    OPEN
    Title: The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicity
    Journal Name: Journal of Cell Biology
    Publisher: Rockefeller University Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1083/jcb.202010065
    Citation Count: 17
  • Summary Details
    RESTRICTED
    Title: Autonomic dysfunction is associated with neuropsychological impairment in Lewy body disease
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00415-020-09783-7
    Citation Count: 25
  • Summary Details
    OPEN
    Title: A person-centered approach to characterizing longitudinal ambulatory impairment in Parkinson's disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-024-62179-9
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Chemogenomic Profiling of Endogenous PARK2 Expression Using a Genome-Edited Coincidence Reporter
    Journal Name: ACS Chemical Biology
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/cb5010417
    Citation Count: 55
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.